blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4013776

EP4013776 - INTERLEUKIN-2 MUTEINS FOR THE EXPANSION OF T-REGULATORY CELLS [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  20.05.2022
Database last updated on 11.05.2024
FormerThe international publication has been made
Status updated on  19.02.2021
Formerunknown
Status updated on  08.09.2020
Most recent event   Tooltip12.04.2024Change - divisional application(s)published on 15.05.2024 [2024/20]
Applicant(s)For all designated states
Amgen Inc.
One Amgen Center Drive
Thousand Oaks, CA 91320-1799 / US
[2022/25]
Inventor(s)01 / BATES, Darren L.
c/o Amgen Inc. One Amgen Center Drive Law Dept-
Patent Operations, Mail Stop 28-5-A
Thousand Oaks, California 91320-1799 / US
02 / SOHN, Sue J.
c/o Amgen Inc. One Amgen Center Drive Law Dept-
Patent Operations, Mail Stop 28-5-A
Thousand Oaks, California 91320-1799 / US
03 / CATTERALL, Hannah
c/o Amgen Inc. One Amgen Center Drive Law Dept-
Patent Operations, Mail Stop 28-5-A
Thousand Oaks, California 91320-1799 / US
04 / WANG, Zhulun
c/o Amgen Inc. One Amgen Center Drive Law Dept-
Patent Operations, Mail Stop 28-5-A
Thousand Oaks, California 91320-1799 / US
 [2022/25]
Representative(s)Lau, Sarah Jane, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[2022/25]
Application number, filing date20764500.313.08.2020
[2022/25]
WO2020US46202
Priority number, dateUS201962886283P13.08.2019         Original published format: US 201962886283 P
[2022/25]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021030602
Date:18.02.2021
Language:EN
[2021/07]
Type: A1 Application with search report 
No.:EP4013776
Date:22.06.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 18.02.2021 takes the place of the publication of the European patent application.
[2022/25]
Search report(s)International search report - published on:EP18.02.2021
ClassificationIPC:C07K14/55, A61K38/20, A61P3/10, A61P19/02, A61P29/00, A61P37/06
[2022/25]
CPC:
C07K14/55 (EP,CN,IL,KR,US); A61K38/00 (EP,CN,IL); A61K38/2013 (KR,US);
A61K47/6813 (CN); A61P1/00 (CN); A61P11/06 (CN);
A61P19/02 (EP,CN,IL,KR,US); A61P29/00 (EP,CN,IL,KR); A61P3/10 (EP,CN,IL,KR,US);
A61P37/06 (EP,CN,IL,US); A61P9/10 (CN); A61P9/14 (CN);
C12N15/85 (CN); C12N5/0637 (CN); C07K2319/30 (EP,CN,IL,KR);
C12N2501/2302 (CN); C12N2800/107 (CN) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/25]
Extension statesBA10.02.2022
ME10.02.2022
Validation statesMA10.02.2022
TN10.02.2022
TitleGerman:INTERLEUKIN-2-MUTEINE ZUR EXPANSION VON T-REGULATORISCHEN ZELLEN[2022/25]
English:INTERLEUKIN-2 MUTEINS FOR THE EXPANSION OF T-REGULATORY CELLS[2022/25]
French:MUTÉINES DE L'INTERLEUKINE-2 POUR L'EXPANSION DE LYMPHOCYTES T RÉGULATEURS[2022/25]
Entry into regional phase10.02.2022National basic fee paid 
10.02.2022Designation fee(s) paid 
10.02.2022Examination fee paid 
Examination procedure10.02.2022Examination requested  [2022/25]
10.02.2022Date on which the examining division has become responsible
03.10.2022Amendment by applicant (claims and/or description)
Divisional application(s)EP24168750.8
Fees paidRenewal fee
19.08.2022Renewal fee patent year 03
22.08.2023Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]WO9960128  (BAYER AG [US], et al) [Y] 1-80 * the whole document * * page 2, paragraph 2 * * pages 28-30; examples 5-6; table 1 *;
 [Y]WO2009061853  (MASSACHUSETTS INST TECHNOLOGY [US], et al) [Y] 1-80 * the whole document * * pages 1,6 *;
 [Y]WO2014153111  (AMGEN INC [US]) [Y] 1-80 * the whole document * * pages 1-2, 44; figures 2, 3, 4, 8-13; example 3; claim -; sequences 32-38 *;
 [Y]WO2016164937  (AMGEN INC [US]) [Y] 1-80 * the whole document * * claims; p. 2, para. 4 to p. 5, para. 1; p. 18, para. 1; p. 4, last para. to p. 5, last para.; claims 4-5, 18-21; p. 3, para. 2; Fig. 8-13, Ex. 3, 4; SEQ 17-18; p. 60; p. 63, Ex. 6; Fig. 17 and legend; p. 3, para. 2; claims 114-117; claims 12-15, 77-93; Ex. 3, p. 57; Fig. 3, 4; Ex. 13, p. 73-74; *;
 [Y]WO2017044464  (UNIV LELAND STANFORD JUNIOR [US], et al) [Y] 1-80 * the whole document * * paragraphs [[098]] - [[099]]; claim -; sequence - *;
 [A]  - LAURENCE B. PETERSON ET AL, "A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease", JOURNAL OF AUTOIMMUNITY, GB, (20181113), vol. 95, doi:10.1016/j.jaut.2018.10.017, ISSN 0896-8411, pages 1 - 14, XP055746622 [A] 1-80 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.jaut.2018.10.017
by applicantUS233
 US4447
 US3691016
 US3773919
 US3969287
 US4179337
 US4195128
 US4229537
 US4247642
 EP0036676
 US4301144
 US4330440
 EP0058481
 EP0088046
 US4439196
 US4447224
 US4475196
 US4486194
 US4487603
 US4496689
 EP0133988
 EP0143949
 US4596556
 US4640835
 US4670417
 WO8705330
 US4791192
 US4790824
 EP0367566
 US4941880
 US4965195
 US4968607
 US5064413
 EP0460846
 US5312335
 US5383851
 US5399163
 US6037525
 US6177612
 US6239328
 US6245974
 US6388066
 US7129062
 WO2006138181
 US7259010
 US7317091
 US7326567
 US7422874
 WO2009089004
 US7695963
 WO2010085495
 WO2011063348
    - J. SEHOULI et al., Epigenetics, (20110000), vol. 6, no. 2, pages 236 - 246
    - SMITHWATERMAN, Adv. Appl. Math., (19810000), vol. 2, page 482
    - NEEDLEMANWUNSCH, J. Mol. Biol., (19700000), vol. 48, page 443
    - PEARSONLIPMAN, Proc. Nat. Acad. Sci. U.S.A., (19880000), vol. 85, page 2444
    - DEVEREUX et al., Nucl. Acid Res., (19840000), vol. 12, pages 387 - 395
    - "Current Methods in Sequence Comparison and Analysis", Macromolecule Sequencing and Synthesis, Selected Methods and Applications, Alan R. Liss, Inc., (19880000), pages 127 - 149
    - FENGDOOLITTLE, J. Mol. Evol., (19870000), vol. 35, pages 351 - 360
    - HIGGINSSHARP, CABIOS, (19890000), vol. 5, pages 151 - 153
    - ALTSCHUL et al., J. Mol. Biol., (19900000), vol. 215, pages 403 - 410
    - ALTSCHUL et al., Nucleic Acids Res., (19970000), vol. 25, pages 3389 - 3402
    - KARIN et al., Proc. Natl. Acad. Sci. U.S.A., (19930000), vol. 90, pages 5873 - 5787
    - ALTSCHUL et al., Methods in Enzymology, (19960000), vol. 266, pages 460 - 480
    - ALTSCHUL et al., Nucl. Acids Res., (19930000), vol. 25, pages 3389 - 3402
    - STROHL, Curr. Opin. Biotech., (20090000), vol. 20, pages 685 - 691
    - DEBOER et al., Proc. Natl. Acad. Sci. U.S.A., (19830000), vol. 80, pages 21 - 25
    - APLINWRISTON, CRC Crit. Rev. Biochem., (19810000), pages 259 - 306
    - HAKIMUDDIN et al., Arch. Biochem. Biophys., (19870000), vol. 259, page 52
    - EDGE et al., Anal. Biochem., (19810000), vol. 118, page 131
    - THOTAKURA et al., Meth. Enzymol., (19870000), vol. 138, page 350
    - DUSKIN et al., J. Biol. Chem., (19820000), vol. 257, page 3105
    - SAIKI et al., Science, (19880000), vol. 239, page 487
    - SAMBROOK et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, (19890000), pages 189 - 196
    - BENOISTCHAMBON, Nature, (19810000), vol. 290, pages 304 - 310
    - THORNSEN et al., Proc. Natl. Acad. U.S.A., (19840000), vol. 81, pages 659 - 663
    - YAMAMOTO et al., Cell, (19800000), vol. 22, pages 787 - 797
    - WAGNER et al., Proc. Natl. Acad. Sci. U.S.A., (19810000), vol. 78, pages 1444 - 1445
    - PRINSTER et al., Nature, (19820000), vol. 296, pages 39 - 42
    - VILLA-KAMAROFF et al., Proc. Natl. Acad. Sci. U.S.A., (19780000), vol. 75, pages 3727 - 3731
    - GROSSCHEDL et al., Cell, (19840000), vol. 38, pages 647 - 658
    - ORNITZ et al., Cold Spring Harbor Symp. Quant. Biol., (19860000), vol. 50, pages 399 - 409
    - MACDONALD, Hepatology, (19870000), vol. 7, pages 425 - 515
    - MOGRAM et al., Nature, (19850000), vol. 314, pages 283 - 286
    - ALEXANDER et al., Mol. Cell. Biol., (19870000), vol. 7, pages 1436 - 1444
    - KOLLIAS et al., Cell, (19860000), vol. 46, pages 485 - 495
    - PINKERT et al., Genes and Devel., (19870000), vol. 1, pages 161 - 171
    - KRUMLAUF et al., Mol. Cell. Biol., (19850000), vol. 5, pages 1639 - 1648
    - HAMMER et al., Science, (19870000), vol. 253, pages 53 - 58
    - READHEAD et al., Cell, (19870000), vol. 48, pages 703 - 712
    - MASON et al., Science, (19860000), vol. 234, pages 1372 - 1378
    - COSMAN et al., Nature, (19840000), vol. 312, page 768
    - ALDRICH et al., Biotechnol Prog., (20030000), vol. 19, pages 1433 - 38
    - GLUZMAN et al., Cell, (19810000), vol. 23, page 175
    - RASMUSSEN et al., Cytotechnology, (19980000), vol. 28, page 31
    - MCMAHAN et al., EMBO J., (19910000), vol. 10, page 2821
    - LUCKOWSUMMERS, Bio/Technology, (19880000), vol. 6, page 47
    - EPPSTEIN et al., Proc. Natl. Acad. Sci. U.S.A., (19850000), vol. 82, pages 3688 - 3692
    - SIDMAN et al., Biopolymers, (19830000), vol. 2, pages 547 - 556
    - LANGER et al., J. Biomed. Mater. Res., (19810000), vol. 15, pages 167 - 277
    - LANGER, Chem. Tech., (19820000), vol. 12, pages 98 - 105
    - ARAKAWA et al., "Solvent interactions in pharmaceutical formulations", Pharm Res., (19910000), vol. 8, no. 3, doi:10.1023/A:1015825027737, pages 285 - 91, XP009052919

DOI:   http://dx.doi.org/10.1023/A:1015825027737
    - "Physical stabilization of proteins in aqueous solution,'' in: RATIONAL DESIGN OF STABLE PROTEIN FORMULATIONS: THEORY AND PRACTICE", KENDRICK et al., Pharmaceutical Biotechnology, (20020000), vol. 13, pages 61 - 84
    - RANDOLPH et al., "Surfactant-protein interactions", Pharm Biotechnol., (20020000), vol. 13, doi:10.1007/978-1-4615-0557-0_7, pages 159 - 75, XP055647590

DOI:   http://dx.doi.org/10.1007/978-1-4615-0557-0_7
 WO1993US00829
 WO2006US22599
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.